Results 121 to 130 of about 2,867 (194)

Continuous evolution of a halogenase enzyme with improved solubility and activity for sustainable bioproduction. [PDF]

open access: yesNat Commun
Pulschen AA   +10 more
europepmc   +2 more sources

Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT<sub>1A</sub> Receptor for Therapeutic Potential in Depression and Anxiety. [PDF]

open access: yesResearch (Wash D C)
Li SJ   +16 more
europepmc   +1 more source

Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention. [PDF]

open access: yesJ Headache Pain
Guerzoni S   +6 more
europepmc   +1 more source

Discovery of Iboga-Derived Ligands for the Sigma‑2 Receptor. [PDF]

open access: yesACS Bio Med Chem Au
Hughes AJ, Talbert JA, Townsend SD.
europepmc   +1 more source

Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes. [PDF]

open access: yesTransl Psychiatry
d'Andrea G   +15 more
europepmc   +1 more source

Chemical Reactivity Parameters to Analyze Psychedelics: How Do We Explain the Potency of the Drugs? [PDF]

open access: yesACS Omega
Martínez A   +5 more
europepmc   +1 more source

Indolethylamine <i>N</i>-Methyltransferase Deletion Impacts Mouse Behavior without Disrupting Endogenous Psychedelic Tryptamine Production. [PDF]

open access: yesACS Chem Neurosci
Hatzipantelis CJ   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy